These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24907513)

  • 1. Signaling mechanisms regulating Wallerian degeneration.
    Freeman MR
    Curr Opin Neurobiol; 2014 Aug; 27():224-31. PubMed ID: 24907513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons.
    Adalbert R; Morreale G; Paizs M; Conforti L; Walker SA; Roderick HL; Bootman MD; Siklós L; Coleman MP
    Neuroscience; 2012 Dec; 225():44-54. PubMed ID: 22960623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy.
    Adalbert R; Nógrádi A; Szabó A; Coleman MP
    Eur J Neurosci; 2006 Oct; 24(8):2163-8. PubMed ID: 17074042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wallerian degeneration, wld(s), and nmnat.
    Coleman MP; Freeman MR
    Annu Rev Neurosci; 2010; 33():245-67. PubMed ID: 20345246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.
    Avery MA; Rooney TM; Pandya JD; Wishart TM; Gillingwater TH; Geddes JW; Sullivan PG; Freeman MR
    Curr Biol; 2012 Apr; 22(7):596-600. PubMed ID: 22425157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wallerian degeneration of zebrafish trigeminal axons in the skin is required for regeneration and developmental pruning.
    Martin SM; O'Brien GS; Portera-Cailliau C; Sagasti A
    Development; 2010 Dec; 137(23):3985-94. PubMed ID: 21041367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle.
    Parson SH; Ribchester RR; Davie N; Gandhi NP; Malik RQ; Gillingwater TH; Thomson D
    J Neurosci Res; 2004 Apr; 76(1):64-75. PubMed ID: 15048930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotyping methods to detect a unique neuroprotective factor (Wld(s)) for axons.
    Mi W; Conforti L; Coleman MP
    J Neurosci Methods; 2002 Jan; 113(2):215-8. PubMed ID: 11772443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model.
    Beirowski B; Babetto E; Coleman MP; Martin KR
    Eur J Neurosci; 2008 Sep; 28(6):1166-79. PubMed ID: 18783366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.
    Shen H; Hyrc KL; Goldberg MP
    Neurobiol Dis; 2013 Nov; 59():69-79. PubMed ID: 23892229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarm1 Deletion, but Not Wld
    Gilley J; Ribchester RR; Coleman MP
    Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death Receptor 6 Promotes Wallerian Degeneration in Peripheral Axons.
    Gamage KK; Cheng I; Park RE; Karim MS; Edamura K; Hughes C; Spano AJ; Erisir A; Deppmann CD
    Curr Biol; 2017 Mar; 27(6):890-896. PubMed ID: 28285993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo.
    Beirowski B; Babetto E; Gilley J; Mazzola F; Conforti L; Janeckova L; Magni G; Ribchester RR; Coleman MP
    J Neurosci; 2009 Jan; 29(3):653-68. PubMed ID: 19158292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal Degeneration in Retinal Ganglion Cells Is Associated with a Membrane Polarity-Sensitive Redox Process.
    Almasieh M; Catrinescu MM; Binan L; Costantino S; Levin LA
    J Neurosci; 2017 Apr; 37(14):3824-3839. PubMed ID: 28275163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.
    Wang AL; Yuan M; Neufeld AH
    J Neurosci Res; 2006 Dec; 84(8):1799-807. PubMed ID: 17022038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential protection of neuromuscular sensory and motor axons and their endings in Wld(S) mutant mice.
    Oyebode OR; Hartley R; Singhota J; Thomson D; Ribchester RR
    Neuroscience; 2012 Jan; 200():142-58. PubMed ID: 22062136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function.
    Jia H; Yan T; Feng Y; Zeng C; Shi X; Zhai Q
    Neurosci Lett; 2007 Feb; 413(1):46-51. PubMed ID: 17207927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.
    Beirowski B; Morreale G; Conforti L; Mazzola F; Di Stefano M; Wilbrey A; Babetto E; Janeckova L; Magni G; Coleman MP
    Neuroscience; 2010 Mar; 166(1):201-11. PubMed ID: 20018231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.